Polymorphisms in complement system genes and risk of non-Hodgkin lymphoma.

Polymorphisms in complement system genes and risk of non-Hodgkin lymphoma.
复制标题

DOI:
10.1002/em.21675
复制
发表时间:
2012-03
影响因子:
2.8
通讯作者:
Lan, Qing
Lan, Qing
中科院分区:
环境科学与生态学3区
文献类型:
--
作者:
Bassig, Bryan A.;Zheng, Tongzhang;Zhang, Yawei;Berndt, Sonja I.;Holford, Theodore R.;Hosgood, H. Dean, III;Hu, Wei;Leaderer, Brian;Yeager, Meredith;Menashe, Idan;Boyle, Peter;Xu, Jun;Zou, Kaiyong;Zhu, Yong;Chanock, Stephen;Rothman, Nathaniel;Lan, Qing

文献摘要

参考文献

被引文献

相似文献

补体系统在炎症和免疫反应中起着重要作用,最近的证据表明它也可能在淋巴瘤发生中起作用。我们在康涅狄格州的妇女中进行了一项基于人群的病例对照研究,评估了补体系统基因的遗传变异与非霍奇金淋巴瘤(NHL)风险之间的关系。在432例高加索事件病例和494例频率匹配的对照中,对30个补体基因的标签SNP进行基因分型。一项基于基因的分析,调整了每个基因中基因分型的标签SNP的数量,显示C1 RL基因与NHL总体(P = 0.04)以及弥漫性大B细胞淋巴瘤(DLBCL)(P = 0.01)显著相关。基于SNP的分析表明,C1 RL rs3813729的C>T碱基替换(比值比(OR)CT = 0.60,95%置信区间(CI)= 0.42-0.87,Ptrend = 0.0062)与总体NHL和DLBCL风险降低相关(ORCT = 0.39,95% CI = 0.20-0.73; P趋势= 0.0034)。此外,两个补体基因中的SNP(C2 rs 497309,A>C和C3 rs344550,G>C)与边缘区淋巴瘤(MZL)正相关,C1 QG与CLL/SLL相关,但这些结果基于有限数量的病例。我们的研究结果表明补体系统在NHL易感性中的潜在作用;然而,我们的研究结果应被视为探索性的,需要进一步的重复来澄清这些初步发现。
The complement system plays an important role in inflammatory and immune responses, and recent evidence has suggested that it may also play a role in lymphomagenesis. We evaluated the association between genetic variation in complement system genes and risk of non-Hodgkin lymphoma (NHL) in a population-based case–control study conducted among women in Connecticut. Tag SNPs in 30 complement genes were genotyped in 432 Caucasian incident cases and 494 frequency-matched controls. A gene-based analysis that adjusted for the number of tag SNPs genotyped in each gene showed a significant association with NHL overall (P = 0.04) as well as with diffuse large B-cell lymphoma (DLBCL) (P = 0.01) for the C1RL gene. A SNP-based analysis showed that a C>T base substitution for C1RL rs3813729 (odds ratio (OR)CT = 0.60, 95% confidence interval (CI) = 0.42–0.87, Ptrend = 0.0062) was associated with a decreased risk of overall NHL, as well as for DLBCL (ORCT = 0.39, 95% CI = 0.20–0.73; Ptrend = 0.0034). Additionally, SNPs (C2 rs497309, A>C and C3 rs344550, G>C) in two complement genes were positively associated with marginal zone lymphoma (MZL) and C1QG was associated with CLL/SLL, but these results were based on a limited number of cases. Our results suggest a potential role of the complement system in susceptibility to NHL; however, our results should be viewed as exploratory and further replication is needed to clarify these preliminary findings.
DOI: 10.2353/ajpath.2007.070166
发表时间: 2007-09-01
影响因子: 6
作者:
Markiewski, Maciej M.;Lambris, John D.
通讯作者: Lambris, John D.
DOI: 10.1097/01.md.0000152371.22747.1e
发表时间: 2005-01-01
期刊: MEDICINE
影响因子: 1.6
作者:
Jönsson, G;Truedsson, L;Sjöholm, AG
通讯作者: Sjöholm, AG
DOI: 10.1182/blood-2005-10-4160
发表时间: 2006-05-15
期刊: BLOOD
影响因子: 20.3
作者:
Lan, Qing;Zheng, Tongzhang;Chanock, Stephen
通讯作者: Chanock, Stephen
DOI: 10.1046/j.1365-2567.2003.01569.x
发表时间: 2003-02-01
期刊: IMMUNOLOGY
影响因子: 6.4
作者:
Arredouani, M;Matthijs, P;Stevens, E
通讯作者: Stevens, E
DOI: 10.1007/s00439-004-1157-z
发表时间: 2004-09-01
期刊: HUMAN GENETICS
影响因子: 5.3
作者:
Hasegawa, K;Tamari, M;Suzuki, Y
通讯作者: Suzuki, Y